Omeprazole vs Esomeprazole in Pakistan: Risek, Nexum & Esso Compared

Walk into any pharmacy from Saddar to Bahria Town and the two most-stocked acid medicines on the shelf are Risek and Nexum. The pharmacist usually offers whichever has a better margin that month. Patients pick by price, by what the doctor scribbled, or by what worked for a cousin. The actual pharmacological difference between the two drugs is small but real, and choosing well matters when you are about to spend weeks on a daily capsule that quietly changes how your gut absorbs minerals and vitamins.

What omeprazole and esomeprazole actually do

Both drugs belong to the proton pump inhibitor (PPI) class. They bind irreversibly to the H+/K+ ATPase enzyme in the stomach's parietal cells, the enzyme that pumps hydrogen ions into the gastric lumen. Once a PPI molecule attaches to a pump, that pump is done for the rest of its life. The cells make new pumps over 24 to 72 hours, which is why PPIs keep working long after the drug has cleared from the blood and why a single morning dose suppresses acid for most of the day.

Omeprazole is a 50:50 racemic mixture: half of the molecules are the left-handed (S-) form and half are the right-handed (R-) form. Esomeprazole is the pure left-handed form, isolated and sold on its own. The R-form is metabolized faster by the liver enzyme CYP2C19, so the S-form alone reaches higher and more predictable blood levels. In healthy volunteers, esomeprazole 40 mg produces about 30 to 40 percent more total acid suppression over 24 hours than omeprazole 20 mg.

That difference matters more in some patients than others. About one in five South Asians has a fast-metabolizer CYP2C19 genotype that chews through omeprazole quickly. For them, esomeprazole's edge is more pronounced. For everyone else, omeprazole at the right dose works fine.

Risek, Nexum, Esso: which brand is which in Pakistan

Pakistani pharmacies stock multiple brands of each PPI. The names are easy to mix up.

Risek dominates the omeprazole market by a wide margin and sets the reference price. On the esomeprazole side, Nexum and Esso compete head-to-head; Lexum is a third option that some prescribers default to. The active ingredient is the same within each generic, so the choice between Nexum, Esso, and Lexum is largely about availability and patient preference, not pharmacology. Always check the strength on the strip before swallowing; 20 mg and 40 mg capsules look nearly identical in the same brand family.

When omeprazole (Risek) is the right choice

Omeprazole 20 mg before breakfast, taken as a short 14-day course, is appropriate for several common Pakistani complaints:

• Heartburn or sour belching that has happened a few times a week for the last month, especially after late-night oily meals.
• Confirmed mild gastritis on endoscopy without ulcers.
• Pre-treatment alongside antibiotics in a 14-day Helicobacter pylori eradication course (the standard "triple therapy" used in Pakistan combines a PPI with clarithromycin and amoxicillin).
• Preventive use during a course of NSAIDs (Brufen, Disprin, Ponstan) in patients over 60 or with prior ulcer history.

For most of these uses, the meaningful clinical question is not omeprazole-versus-esomeprazole but whether 14 days of PPI therapy actually resolves the symptom. If yes, stop the drug and address the trigger (chai habit, sleep position, meal timing). If symptoms return within four weeks of stopping, that is a signal to investigate rather than restart on autopilot.

When esomeprazole (Nexum) is the better pick

Esomeprazole is the more reasonable choice in three specific scenarios:

1. Severe GERD with oesophagitis confirmed on endoscopy. The dose-response curve favours esomeprazole 40 mg over omeprazole 20 mg for healing the oesophageal lining, with international guidelines (NICE, ACG) recognizing this distinction.
2. Failed omeprazole trial. If a patient has had a full 14-day course of omeprazole 20 mg twice daily and symptoms persist, switching to esomeprazole 40 mg before changing class is a reasonable step.
3. Need for predictable suppression. Patients with confirmed CYP2C19 fast-metabolizer status, or those who have responded inconsistently to omeprazole on repeat courses, get more reliable acid control on esomeprazole.

What esomeprazole does not meaningfully outperform omeprazole on is mild, occasional heartburn or routine ulcer prophylaxis during NSAID use. For those, the extra cost of Nexum or Esso buys very little extra benefit.

Dose and timing: the part most people get wrong

PPIs work best when taken on an empty stomach, 30 to 60 minutes before the first meal of the day. The reason is mechanistic: the drug needs to be in the bloodstream when the proton pumps are activated by food, otherwise it cannot bind to enough pumps in their working state. Taking a PPI after meals reduces its effectiveness by around half.

Standard adult doses are: omeprazole 20 mg once daily (40 mg in severe disease); esomeprazole 20 mg once daily for maintenance, 40 mg for active disease. Both can be given twice daily for the first week of severe GERD, splitting the dose to before breakfast and before dinner. Treatment courses run 4 to 8 weeks for healing, with shorter 14-day courses appropriate for occasional symptom flares. Both drugs can be opened (Risek and Nexum both come as enteric-coated capsules) and the granules sprinkled on apple sauce for children or patients with swallowing difficulty; do not crush or chew.

Side effects and the long-term concerns nobody mentions at the counter

Short-term, both drugs are well tolerated. Mild headache, nausea, abdominal cramps, and constipation affect under 5 percent of users and usually settle within a week. Diarrhoea is somewhat more common with esomeprazole than omeprazole.

The bigger story is long-term use. PPI courses that stretch into months or years carry several non-trivial risks:

• Vitamin B12 deficiency. Gastric acid is needed to liberate B12 from food protein. After 12+ months of daily PPI use, deficiency rates climb meaningfully, especially in vegetarians and patients over 60. Annual B12 check is reasonable for anyone on a year-plus PPI course.
• Magnesium and iron absorption. Both can drop with prolonged PPI use; symptoms include muscle cramps, fatigue, and worsening of pre-existing anaemia.
• Bone density. Long-term high-dose PPI is associated with a small but real increase in hip and spine fracture risk.
• Clostridioides difficile and other enteric infections. Acid is a defense against swallowed bacteria. Suppressed acid raises infection risk by roughly 70 percent.
• Rebound acid hypersecretion. Stopping a PPI cold turkey after weeks of use causes a temporary acid surge for 2 to 4 weeks; this is often mistaken for "needing" the drug long term. A taper (alternate-day dosing for a week, then twice-weekly for a week) reduces rebound.

None of these risks should stop a short course where it is genuinely needed. They are reasons to avoid casual indefinite use and to revisit the prescription every 8 weeks.

Related Medicines & Tools

Frequently Asked Questions

Can I take Risek and Nexum together?

No. Both drugs hit the same proton pump enzyme; stacking them does not double acid suppression, it just gives you more side effects and cost. If Risek 20 mg is not enough, the right escalation is Risek 20 mg twice daily, or switching to Nexum 40 mg once daily. Speak to a doctor before doubling any PPI past 8 weeks.

Is Nexum stronger than Risek mg for mg?

At the same milligram dose, esomeprazole (Nexum) achieves about 30 to 40 percent more 24-hour acid suppression than omeprazole (Risek). At standard doses (Risek 20 mg vs Nexum 40 mg) the difference is bigger but you are paying for more drug. For occasional reflux, the extra suppression is rarely necessary and most patients do equally well on either.

Can I take Risek on alternate days to save cost?

Once symptoms are controlled and you are in maintenance, alternate-day Risek can work and is a common down-titration step before stopping. During an active flare, daily dosing for the full course (usually 14 to 28 days) is needed; alternate-day from day one leaves too many pumps active and is the most common reason patients say "Risek did not work for me".

Will Risek or Nexum interact with my other medicines?

Both PPIs reduce the absorption of clopidogrel (Plavix), antifungals like ketoconazole, and the HIV drug atazanavir. Both raise the blood levels of methotrexate. If you are on heart medication, antifungals, or chemotherapy, mention the PPI to your prescribing doctor before starting; an alternative class (H2 blocker like ranitidine, which was banned but is being reformulated, or famotidine) may be safer.

How long can I stay on Risek or Nexum safely?

Short answer: as long as the underlying condition needs it, but with annual review. Patients with confirmed Barrett's oesophagus, Zollinger-Ellison syndrome, or severe erosive oesophagitis may need lifelong PPI therapy and that is reasonable. For routine GERD, the goal is the shortest effective course; review every 8 weeks and trial a step-down to alternate-day dosing or an H2 blocker after symptoms have been controlled for 3 months.

Related posts

Panadol Price in Pakistan 2026. Every Variant Compared

5 min read

Stomach Pain Medicine in Pakistan: Picking the Right Tablet for Cramps, Acidity, or Gas

9 min read

Panadol Extra Uses, Caffeine Content & Side Effects Explained (Pakistan)

6 min read

Panadol CF Uses, Side Effects & Dosage in Pakistan (2026 Guide)

6 min read